Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Captor Therapeutics secures USD 2 million non-dilutive grant from The Michael J. Fox Foundation for its NEK7 neurodegenerative disease project.

PRIVATEOct 13, 2026

Amount Raised

$2 Million

Round Type

Grant

PolandBiotechnologyHealth CareTherapeutics

Investors

The Michael J. Fox Foundation

Description

Captor Therapeutics secured a USD 2 million grant from The Michael J. Fox Foundation on September 29, 2026, to support development of a brain-penetrant NEK7 candidate for neurodegenerative diseases, including Parkinson's disease. The non-dilutive award does not result in share dilution or convertible debt issuance. Captor retains intellectual property rights connected with the NEK7 project

Company Information

Company

Captor Therapeutics

Location

Poland

About

Captor Therapeutics is a biotechnology company focused on developing brain-penetrant candidates for neurodegenerative diseases, including Parkinson's disease. The company is developing its NEK7 project with support from The Michael J. Fox Foundation. Captor Therapeutics is listed on the Warsaw Stock Exchange under ticker CTX. As of mid-2026, the company had a cash runway extending through Q3 2027.

Fundz sees it the moment Captor Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Captor Therapeutics's next move

See what Strategic adds

Captor Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.